Search

Author/Creator Cui, Yaoyuan

1. AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway. (1st March 2022)

Authors:
Liu, Chen; Huang, Yuhan; Qin, Tianyu; You, Lixin; Lu, Funian; Hu, Dianxing; Xiao, Rourou; Qin, Xu; Guo, Ensong; Yang, Bin; Li, Xi; Fan, Junpeng; Li, Xiong; Fu, Yu; Liu, Si; Wang, Zhuozi; Dou, Yingyu; Wang, Wei; Li, Wenting; Yang, Xiaohang
Journal:
Cancer letters
Issue:
Volume 528(2022)
Page Start:
31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer. Issue 21 (26th May 2022)

Authors:
Xiao, Rourou; You, Lixin; Zhang, Li; Guo, Xichen; Guo, Ensong; Zhao, Faming; Yang, Bin; Li, Xi; Fu, Yu; Lu, Funian; Wang, Zizhuo; Liu, Chen; Peng, Wenju; Li, Wenting; Yang, Xiaohang; Dou, Yingyu; Liu, Jingbo; Wang, Wei; Qin, Tianyu; Cui, Yaoyuan
Journal:
Advanced science
Issue:
Volume 9:Issue 21(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search